- QMRO Home
- Barts Cancer Institute
- Centre for Haemato-Oncology
- Radiation therapy with tositumomab (B1) anti-CD20 monoclonal antibody initiates extracellular signal-regulated kinase/mitogen-activated protein kinase-dependent cell death that overcomes resistance to apoptosis
Browse
Administrators only